About AEI My AEI Support AEI Contact AEI
Home Events Books Short Publications Research Areas Scholars & Fellows


Search


FindAdvanced Search



HEALTH POLICY AT AEI
Contact Us
Events
Past Events
Books
Short Publications
Scholars
Links

Home >  Research Areas >  Health Policy Studies at AEI >  Events >  Browse by Event Materials
Browse by Event Materials
   Summaries
  Aging and Future Health Care Spending
  Another Warning for Medicare?
  Oncology Drug Development: Rethinking FDA Oversight
  Can We Get It for You Retail? Moving Beyond Wholesale Markets for Health-Care Services
  The Business of Health: How Does the U.S. Health-Care System Compare to Systems in Other Countries?
  [View All Summaries]
   Transcripts
  Cracking Down on Killer Drugs: Dora Akunyili and the Nigerian Success Story
  Is Free Trade Good for Your Health?
  Oncology Drug Development: Rethinking FDA Oversight
  The U.S. Senate Takes On Medical Malpractice Reform
  Combating the Diseases of Poverty: Aid versus Innovation
  [View All Transcripts]
   Audio
  Aging and Future Health Care Spending
  Cracking Down on Killer Drugs: Dora Akunyili and the Nigerian Success Story
  Is Free Trade Good for Your Health?
  Another Warning for Medicare?
  Oncology Drug Development: Rethinking FDA Oversight
  [View All Audio]
   Video
  Aging and Future Health Care Spending
  Cracking Down on Killer Drugs: Dora Akunyili and the Nigerian Success Story
  Is Free Trade Good for Your Health?
  Another Warning for Medicare?
  Oncology Drug Development: Rethinking FDA Oversight
  [View All Video]


Health and the Income Inequality Hypothesis

Health and the Income Inequality Hypothesis: A Doctrine in Search of Data, by Nicholas Eberstadt and Sally Satel, suggests that income distribution is far less powerful a determinant of population health than the inequality hypothesis holds.


Health Care Matters
In Health Care Matters: Pharmaceuticals, Obesity, and the Quality of Life, Richard D. Miller Jr. and H. E. Frech III argue that policy should no longer be based on the assumption that health-care consumption does not improve health, but rather on a new understanding that such consumption--especially pharmaceutical use--does matter.